Literature DB >> 4534575

Transient EEG abnormalities following lumbar myelography with metrizamide.

B Kaada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4534575     DOI: 10.1177/0284185173014s33546

Source DB:  PubMed          Journal:  Acta Radiol Suppl        ISSN: 0365-5954


× No keyword cloud information.
  14 in total

1.  Potentiation of Amipaque epileptogenic activity by neuroleptics.

Authors:  R E Gonsette; J M Brucher
Journal:  Neuroradiology       Date:  1977-08-25       Impact factor: 2.804

2.  Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography.

Authors:  Y L Yu; G H du Boulay; E Paul
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

3.  Results of a double blind study of three contrast media and technic for lumbosacral radiculography.

Authors:  B Hammer
Journal:  Neuroradiology       Date:  1978-11-24       Impact factor: 2.804

4.  Subclinical organic psychosyndromes on intrathecal injection of metrizamide for lumbar myelography.

Authors:  S Richert; K Sartor; B Holl
Journal:  Neuroradiology       Date:  1979-10-31       Impact factor: 2.804

5.  Direct puncture versus run up cervical myelography with iopamidol: a comparison of side effects, EEG changes and radiographic quality.

Authors:  P Macpherson; E Teasdale; A P McGeorge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

6.  Adverse side effects of metrizamide and iopamidolo in myelography.

Authors:  A Carella; F Federico; F Di Cuonzo; E Vinjau; P Lamberti
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

7.  Electroencephalography (EEG) after introduction of water soluble contrast media into cerebrospinal fluid (CSF).

Authors:  H E Nau
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

8.  Experiences with intrathecally enhanced computed tomography.

Authors:  B Hammer
Journal:  Neuroradiology       Date:  1980       Impact factor: 2.804

9.  Iopamidol (B 15000), a nonionic water-soluble contrast medium for neuroradiology. Part I: Results of a clinical trial for myelography.

Authors:  L Bacarini; T de Nicola; D Gasparini; P Orlando; A Vassallo
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

10.  [Myelography with metrizamide. (Amipaque)].

Authors:  H Vogelsang; R Schmidt; O Busse; U Dangel
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.